Phosphopenic form of osteomalacia in a patient with FGF23 producing tumor

Phosphopenic form of osteomalacia in a patient with FGF23 producing tumor

Oncogenic osteomalacia is an orphan disease caused by the overproduction of fibroblast growth factor 23 (FGF23) in tumors, which leads to impaired bone matrix mineralization. Typical laboratory changes are hypophosphatemia, increased alkaline phosphatase, hyperphosphaturia, and decreased tubular pho...

Full description

Saved in:

Bibliographic Details
Main Authors:	A. S. Pushkareva, E. E. Bibik, A. K. Eremkina, M. V. Degtyarev, N. G. Mokrysheva
Format:	Article
Language:	Russian
Published:	IMA PRESS LLC 2022-05-01
Series:	Научно-практическая ревматология
Subjects:	osteomalacia tumor hypophosphatemia fracture fgf23
Online Access:	https://rsp.mediar-press.net/rsp/article/view/3159
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Tumor-induced phosphopenic osteomalacia: modern approaches to diagnostics and treatment
by: A. A. Kondrashov, et al.
Published: (2024-10-01)

Phosphopenic osteomalacia of tumor genesis under mask of ankylosing spondylitis
by: A. A. Kondrashov, et al.
Published: (2024-08-01)

Hypophosphatemic osteomalacia induced by FGF23-secreting tumor of the left femur
by: S. S. Rodionova, et al.
Published: (2019-12-01)

Phosphate, Fractures, and Frustration—A Missed Diagnosis of Oncogenic Osteomalacia Leading to Multisystem Complication
by: Ryan Michael Wilson, et al.
Published: (2025-08-01)

Pathological Femoral Fracture due to Osteoporosis and Hypophosphatemic Osteomalacia Following Adefovir Therapy in a Patient with Chronic Hepatitis B
by: Sevilay Batıbay, et al.
Published: (2018-08-01)

Tumor-Induced Osteomalacia in a Patient With FGF23-Amplified Lung Adenocarcinoma and FGF23-Deleted SCLC: Case Report
by: Marcello Moro Queiroz, MD, et al.
Published: (2025-06-01)

FGF23-related hypophosphatemia in a patient with small cell lung cancer: a case report and literature review
by: Hajime Kato, et al.
Published: (2023-10-01)

Case Report: Phosphaturic mesenchymal tumor presenting solely as knee pain without hypophosphatemia
by: Qianqian Cao, et al.
Published: (2025-05-01)

Management of anemia in inflammatory bowel disease: a challenge in everyday clinical practice
by: Edyta Tulewicz-Marti, et al.
Published: (2017-12-01)

An unusual cause of osteomalacia in a young lady
by: Angan Karmakar, et al.
Published: (2024-05-01)

Use of burosumab in McCune Albright syndrome: case report and review of literature in mosaic disorders with FGF23 overproduction
by: Alessandro Barbato, et al.
Published: (2025-05-01)

Phosphaturic mesenchymal tumor: Clinicopathological features with outcomes in 10 patients with review of literature
by: Vivek C. Parameshwar, et al.
Published: (2024-04-01)

Advancing patient evidence in XLH (APEX): rationale and design of a real-world XLH global data unification program
by: Maria Luisa Brandi, et al.
Published: (2025-04-01)

The importance of whey protein levels of Klotho and fibroblast growth of factor-23 (fgf-23) as early diagnostic markers of chronic kidney damage
by: L. Yu. Milovanova, et al.
Published: (2014-06-01)

Orthopedic surgical treatment of osteomalacia induced by culprit soft tissue tumor in the hip region: a single-center retrospective study
by: Shuzhong Liu, et al.
Published: (2025-04-01)

Fluoridated Water-Induced Osteomalacia in the Population of Mirpurkhas
by: Mir Mehrab Jan Khetran, et al.
Published: (2023-11-01)

Insufficiency Fracture of the Superior and Inferior Pubic Rami in a Patient with Osteomalacia: Case Report
by: Barış Nacır, et al.
Published: (2010-08-01)

The Roxadustat (FG-4592) ameliorates tubulointerstitial fibrosis by promoting intact FGF23 cleavage
by: Jing Wang, et al.
Published: (2025-04-01)

Occult tumour-induced osteomalacia causing lesion detected by FDG-PET/CT scan
by: Nitin Gupta, et al.
Published: (2020-04-01)

Case report: Prolonged and severe hungry bone syndrome after parathyroidectomy in X-linked hypophosphatemia
by: Giulia Puliani, et al.
Published: (2025-01-01)

Advanced tumour-induced osteomalacia secondary to sinonasal phosphaturic mesenchymal tumour
by: Monica van Wijk, et al.
Published: (2024-10-01)

Osteomalacia due to Vitamin D Deficiency: A Case Report
by: Banu Ordahan, et al.
Published: (2020-08-01)

The Effect of Ferric Carboxymaltose on Fibroblast Growth Factor 23 (FGF23) in Children with Iron Deficiency Anemia Due to Gastrointestinal Diseases
by: Maria Ntoumpara, et al.
Published: (2024-11-01)

The serum levels of FGF23, sclerostin, osteoprotegerin do not explain the inverse relationship between coronary calcifications and bone mineral density evaluated using computed tomography
by: Laurence Ferrières, et al.
Published: (2025-06-01)

Hypoxia Activates FGF-23-ERK/MAPK Signaling Pathway in Ischemia-Reperfusion-Induced Acute Kidney Injury
by: Weihua Liu, et al.
Published: (2024-10-01)

Expression of fibroblast growth factor 23 (FGF23) and αKlotho in two commercial laying hen strains fed with and without dietary mineral P supplements before and after the onset of the laying phase
by: Leonie Meier, et al.
Published: (2025-11-01)

A case report of X-linked hypophosphatemia combined with primary hyperparathyroidism
by: YinQiong Wu, et al.
Published: (2025-07-01)

Expression of FGF23 and α-KLOTHO in Normal Human Kidney Development and Congenital Anomalies of the Kidney and Urinary Tract (CAKUT)
by: Patricija Bajt, et al.
Published: (2025-06-01)

Evaluation of fibroblast growth factor 23 as a marker of severity in stable chronic obstructive pulmonary disease
by: Simarpreet Singh, et al.
Published: (2025-06-01)

Fibroblast Growth Factor 23 and Sarcopenia in Maintenance Haemodialysis Population
by: Limy Wong, et al.
Published: (2025-06-01)

Hypophosphatemic osteomalacia associated with tenofovir: a multidisciplinary approach is required.
by: Giuseppe Vittorio De Socio, et al.
Published: (2012-01-01)

ORAI1, FGF23, PP13, palladin, and supervillin as potential biomarkers in late-onset pre-eclampsia: a comparative study in maternal and cord blood
by: Hatice Argun Atalmis, et al.
Published: (2025-07-01)

Serum FGF-23 and Vitamin D Deficiency as Predictors of Metabolic Syndrome in Chronic Kidney Disease
by: Tazeen Shah, et al.
Published: (2025-04-01)

Correlation of Fibroblast Growth Factor-23 Levels with Hand Grip Strength in Twice Weekly Hemodialysis Patients
by: Aida Lydia, et al.
Published: (2020-03-01)

Distal renal tubular acidosis as a cause of osteomalacia in a patient with primary Sjögren's syndrome
by: Jovelić Aleksandra, et al.
Published: (2005-01-01)

Decoding FGF/FGFR Signaling: Insights into Biological Functions and Disease Relevance
by: Oshadi Edirisinghe, et al.
Published: (2024-12-01)

Forefoot Tumor of Mesenchymal Origin with Hypophosphatemic Osteomalacia: A Case Report
by: Myilvahanan Ganesan, et al.
Published: (2025-06-01)

Expression of FGF23 in patients at different stages of chronic kidney diseases and its correction with left ventricular hypertrophy, PLSγ/calcineurin NFAT signaling pathway
by: ZHANG Yan, et al.
Published: (2019-01-01)

Phosphaturic Mesenchymal Tumor of Tibia: A Challenging Diagnosis Rendered on Percutaneous Core Needle Biopsy
by: Monalisa Hui, et al.

Expression of endothelin in experimental myocardial infarction in a changed concentration of FGF and VEGF
by: M. G. Shurygin, et al.
Published: (2013-02-01)